Enhancing Responsiveness with Embedded Flexibility

by Gwenaël Servant

Pharma’s Almanac Q1 2017

In today’s pharmaceutical marketplace, speed to market is absolutely crucial. CDMOs with built-in flexibility are ideally situated to help drug companies shorten development and commercialization time lines. Flexibility can take many forms — from rapid tech transfer within an internal network to agile manufacturing configurations and use of automation, to the ability to rapidly respond to changing market and customer needs.

News

Servier CDMO expands Preparative Chromatography platform at Normandy Site to support market need

The benefit is the speeding up of clinical supply and subsequent manufacture of complex molecules for medicines at commercial scale.

Thought Leadership

Russian Pharma Market Offers Great Potential for Local Manufacturers

The Russian market presents new growth opportunities for pharmaceutical companies with manufacturing capabilities within the country. Servier Group is well-positioned to serve the market directly with a wide range of solid oral dose products, while Servier CDMO can support other pharmaceutical companies looking to leverage the growth potential but who lack in-country production facilities.

Events

Visit us at CPhI Worldwilde

Servier CDMO will be attending CphI Worldwilde in Messe Frankfurt, Germany from 24 - 26 October 2017.

Events

Visit us at Nordic Life Science Days 2017

Servier CDMO will be attending Nordic Life Science Days 2017 in Copenhague from 12th – 14th September.

Events

Visit us at Chemoutsourcing 2017

Servier CDMO will be attending Chemoutsourcing 2017 in New York from 18th – 20th September.

Thought Leadership

Serialization: The First Steps in Sales Unit Traceability and Data Management

Pharma’s Almanac Q2 2017

Increasing numbers of countries around the world are requiring some level of unit traceability in the pharmaceutical industry. While initially driven by regulations, the impacts of serialization will be far-reaching. Early adopters that implement a strategy that goes beyond compliance to leverage the vast quantities of newly generated data will be well positioned for success in the digital age.

Events

Visit us at BIO International 2017

Servier CDMO will be attending BIO International 2017 in San Diego, CA from 19th – 22nd June. We would welcome the opportunity to meet to learn about your business and discuss ways we may be able collaborate to advance your drug development and manufacturing goals. Contact us at [email protected] to schedule a meeting.
Events

Visit us at Chemspec Europe 2017

Servier CDMO will be attending Chemspec Europe 2017 at the Munich Trade Fair Centre from 31st May – 1st June. We would love to give you a presentation of our services or to discuss your drug substance needs. Contact us to book a meeting.
News

Launch of new website

Servier CDMO has just launched our new website. You can now find out about our Products and Services and our expertise in the development and manufacturing of clinical to commercial drug substance and product. You can also view key information about services and key equipment at each of our manufacturing sites around the world. 

Thought Leadership

Enhancing Responsiveness with Embedded Flexibility

Pharma’s Almanac Q1 2017

In today’s pharmaceutical marketplace, speed to market is absolutely crucial. CDMOs with built-in flexibility are ideally situated to help drug companies shorten development and commercialization time lines. Flexibility can take many forms — from rapid tech transfer within an internal network to agile manufacturing configurations and use of automation, to the ability to rapidly respond to changing market and customer needs.

Thought Leadership

Cultivating a Proactive Quality Culture

Preventing patient risk is perhaps the most important goal for any pharmaceutical manufacturer. The quality of a drug substance or product is directly linked to where and how it’s made. As a result of the gravity of production, management must ensure that process variation is eliminated, consistent quality is guaranteed and there are no threats of defects that may potentially harm patients or interrupt supply. To assure quality, Servier takes a holistic approach, bringing people, process and policy together to create an efficient, agile QA/QC culture. 

Thought Leadership

Evolving Strategic Partnership Models

Pharmaceutical development is growing as the industry gains momentum in response to a broad range of market, regulatory and social trends globally. Advancing science, emerging markets and healthcare models are driving recent innovation and therapeutic success in the pharmaceutical sector, which has become increasingly dependent on partnerships across the supply chain. Collaboration is key to successfully responding to market demand – collaboration between both (bio)pharmaceutical companies and their service providers.

Thought Leadership

Leveraging Effective Partnering Models

Manufacturing Chemist – September 2016.

Accelerating successful drug development to meet global demand.

 

Information Download

Tianjin, China

Servier Tianjin Pharmaceutical Co. Ltd was registered in 2000. It is situated in the Tianjin Economic Technological Development Area, (TEDA) which is ranked as one of the top economic development zones in China. The site is located 45km from Tianjin and 120km from Beijing.

Information Download

Jacarepagua, Brazil

Servier Brazil has been established for 40 years. We acquired a new industrial facility in 1995, located in Petropolis, about 75km from Rio de Janeiro. The Petropolis site produced sprays for the local market, repacking local production and QC analysis for imported product.

Information Download

Cairo, Egypt

Servier Egypt has two sites, situated a kilometer apart at Acacias and Palmiers, 50km from Cairo.

The Acacias site is dedicated to manufacturing activities — consisting of a complete granulation suite, four compression units and two coating pans — alongside Quality Control, Quality Assurance and IT. The Acacias site was built in 1994 and fully renovated in 2010.

Information Download

Nouasseur, Morocco

Servier has been present in Morocco since 1970 producing medicines for the Moroccan market initially under license. In 2002, Servier built a pharmaceutical manufacturing site dedicated to dry forms at the Nouasseur science park situated 25km from Casablanca.

Information Download

Toledo, Spain

Toledo, Spain is located 70km from Madrid. Our Servier CDMO facility has 38 years of experience in fine chemistry, specializing in process development, analytical development and manufacturing. Our manufacturing processes us the most up to date production equipment and control techniques.

Information Download

Madrid, Spain

Servier was first established in Madrid, Spain in 1957. In the 1960s the first pharmaceutical manufacturing operations started, dedicated to domestic market. In 1978, the chemical plant of Toledo was built and in 1982, the Madrid functions moved to the new site.

Information Download

Moscow, Russia

Servier Russia is located in Moscow and has been in operation since 2007. The site has one production unit that is dedicated to dry forms manufacturing.

Information Download

Warsaw, Poland

Manufacturing activities were established in Warsaw 20 years ago. In that time, we have focused on providing high quality pharmaceutical products to patients in Poland and beyond.

Information Download

Arklow, Ireland

Servier (Ireland) Industries Ltd. was established in 1989 and is located in South Dublin. It is now the largest production facility outside France for the Servier group, and is the second strategic location in Servier’s worldwide pharmaceuticals operations. 

Information Download

Gidy, France

Gidy is located near Orleans, 100km from Paris. The site was built in 1972 and has 4 production units: two dedicated to dry forms, one dedicated to liquid and spray forms nearby in Fleury-les-Aubrais, and one additional unit that is currently being transformed into a biotechnology unit, launching in 2019.

Information Download

Bolbec, France

Oril Industrie is one of the two full cGMP chemical production sites of the Servier CDMO network, located in Bolbec (Normandy), between Le Havre and Paris. The Bolbec facility specializes in intermediates and APIs development, production and distribution. Industrial R&D and the production units are at the same location, providing flexibility and efficient processes.

Information Download

Supply Chain

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Packaging

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Drug Product

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Drug Substance

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Clinical Supply

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.